ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,749.00
0.35%
S&P ASX All Technology
3,067.50
0.14%
Brent Oil
82.585
0.00%
US Dollar vs AUD
1.50761
0.00%
Bitcoin
61,132.89
0.55%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Minerva Neurosciences Inc (NERV)

  7. Minerva Neurosciences Inc (NERV) News

NERV

Minerva Neurosciences (NERV)

Minerva Neurosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NERV
DateTimeSourceHeadlineSymbolCompany
01/05/202421:30GlobeNewswire Inc.Minerva Neurosciences Reports First Quarter 2024 Financial Results and Business UpdatesNASDAQ:NERVMinerva Neurosciences Inc
28/02/202400:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NERVMinerva Neurosciences Inc
28/02/202400:00GlobeNewswire Inc.Minerva Neurosciences Receives Complete Response Letter from FDA for New Drug Application for Roluperidone for the Treatment of Negative Symptoms in Patients with SchizophreniaNASDAQ:NERVMinerva Neurosciences Inc
22/02/202423:00GlobeNewswire Inc.Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business UpdatesNASDAQ:NERVMinerva Neurosciences Inc
22/02/202422:30Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:NERVMinerva Neurosciences Inc
07/11/202323:30GlobeNewswire Inc.Minerva Neurosciences Reports 2023 Third Quarter Financial Results and Business UpdatesNASDAQ:NERVMinerva Neurosciences Inc
07/11/202323:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NERVMinerva Neurosciences Inc
06/10/202307:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NERVMinerva Neurosciences Inc
06/10/202307:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NERVMinerva Neurosciences Inc
29/09/202322:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NERVMinerva Neurosciences Inc
29/09/202322:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NERVMinerva Neurosciences Inc
29/09/202306:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NERVMinerva Neurosciences Inc
15/08/202323:28Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:NERVMinerva Neurosciences Inc
15/08/202323:26Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:NERVMinerva Neurosciences Inc
15/08/202323:25Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:NERVMinerva Neurosciences Inc
10/08/202314:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:NERVMinerva Neurosciences Inc
10/08/202307:12Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:NERVMinerva Neurosciences Inc
04/08/202322:07Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:NERVMinerva Neurosciences Inc
01/08/202321:30GlobeNewswire Inc.Minerva Neurosciences Reports 2023 Second Quarter Financial Results and Business UpdatesNASDAQ:NERVMinerva Neurosciences Inc
01/08/202321:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NERVMinerva Neurosciences Inc
08/07/202306:18Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:NERVMinerva Neurosciences Inc
04/07/202306:04Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:NERVMinerva Neurosciences Inc
28/06/202322:38Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NERVMinerva Neurosciences Inc
28/06/202322:37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NERVMinerva Neurosciences Inc
28/06/202322:30GlobeNewswire Inc.Minerva Neurosciences Announces $20 Million in Private Placement Priced at a Premium to MarketNASDAQ:NERVMinerva Neurosciences Inc
20/06/202322:41Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NERVMinerva Neurosciences Inc
15/05/202321:30GlobeNewswire Inc.Minerva Neurosciences Reports 2023 First Quarter Financial Results and Business UpdatesNASDAQ:NERVMinerva Neurosciences Inc
15/05/202321:02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NERVMinerva Neurosciences Inc
10/05/202322:00GlobeNewswire Inc.Minerva Neurosciences Announces Update on its New Drug Application (NDA) for Roluperidone for the Treatment of Negative Symptoms in SchizophreniaNASDAQ:NERVMinerva Neurosciences Inc
08/05/202322:30GlobeNewswire Inc.Minerva Neurosciences to Report First Quarter 2023 Financial Results and Business Updates on May 15, 2023NASDAQ:NERVMinerva Neurosciences Inc
 Showing the most relevant articles for your search:NASDAQ:NERV

Your Recent History

NYSE
VZ
Verizon Communications
COIN
ETHUSD
Ethereum
NYSE
JPM
JP Morgan Chase
NYSE
MRK
Merck
ASX
RIO
Rio Tinto
ASX
ANZ
Australia And New Zealan...
ASX
XFL
S&P ASX 50
ASX
BHP
BHP
FX
EURAUD
Euro vs AUD
NASDAQ
NVDA
NVIDIA
ASX
ORG
Origin Energy
ASX
WOW
Woolworths
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
DIS
Walt Disney
COIN
BTCUSD
Bitcoin
ASX
XMM
S&P ASX 300 Metals and M...
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved